Understanding links between severe periodontitis and gut bacteria and barrier function
Official title: The Intestinal Microbiome: From Systemic Impact to Periodontal Supporting Tissues
Run by Iuliu Hatieganu University of Medicine and Pharmacy · NCT07907224 · Data updated 2026-11-12
This observational study tests whether severe periodontitis is related to small intestinal bacterial overgrowth (SIBO) and changes in gut barrier biomarkers in adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Iuliu Hatieganu University of Medicine and Pharmacy Academic / other |
| Locations | 1 site (Cluj-Napoca) |
| Status | Recruiting |
| Started | October 2, 2026 |
| Main results expected | October 29, 2027 |
| Study ends | September 30, 2029 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07907224 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with Stage III/IV periodontitis (Grade B or C) and sufficient dentition for full-mouth evaluation.
✕Probably not a fit
Individuals without periodontitis or with uncontrolled systemic diseases may not experience any direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will enroll 20 adults with Stage III/IV periodontitis and characterize their oral and gut health using periodontal exams, breath tests for SIBO, and blood tests for gut barrier biomarkers. The study is prospective and exploratory, aiming to describe associations rather than prove causation. Participants will be followed to see if improvements in periodontal health align with changes in SIBO status and biomarker levels. Data on symptoms and lifestyle will help interpret the findings. No healthy control group is included, and results will inform future studies on oral-gut interactions.
Why it matters
Potential benefit: If associations are found, the study could guide future research and inform clinicians about potential gut health considerations for patients with severe periodontitis.
How similar studies have gone: Previous work suggests possible links between oral inflammation and gut microbiota, but human evidence remains preliminary and heterogeneous.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged ≥18 years. * Diagnosis of Stage III/IV periodontitis, Grade B or C, according to the applicable periodontal classification criteria. * Presence of sufficient dentition to permit a meaningful full-mouth periodontal examination. * Ability and willingness to perform the breath test and provide blood samples and questionnaire data. * Written informed consent. * Patients with stable chronic systemic conditions may be included, provided that the condition is clinically controlled and does not meet any exclusion criterion. Relevant systemic diseases and concomitant medications will be recorded and considered as potential confounding factors. Exclusion Criteria: * Uncontrolled or severe systemic disease likely to substantially affect periodontal inflammation, intestinal microbiota, intestinal barrier function, systemic inflammatory status, or the safety of periodontal treatment. * Antibiotic, systemic antifungal, or probiotic therapy within the preceding 4 weeks. * Recent periodontal treatment that could materially influence baseline periodontal or biological measurements. * Diagnosed inflammatory bowel disease, celiac disease, major intestinal surgery, or another major gastrointestinal condition that would substantially interfere with interpretation of SIBO or intestinal barrier-related outcomes. * Current pregnancy or breastfeeding. * Other condition or treatment judged by the investigator to materially interfere with the study outcomes or procedures.
Where it's running
-
Ambulatoriul de Stomatologie al SCJU Cluj-Napoca, România
Cluj-Napoca, Romania Recruiting
Study contacts
- Study coordinator: Damaris Anton, Doctor of Dental Medicine
- Email: damaris.anton@elearn.umfcluj.ro
- Phone: +40770588626
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics with or without vitamin B12 added to non-surgical treatment for advanced periodontitis
This study will see if taking a probiotic lozenge alone or together with vitamin B12 during non-surgical periodontal treatment changes the oral microbiome and helps adults with Stage III or IV periodontitis.
-
Dental Loupes vs. Dental Operating Microscope for Non-Surgical Periodontal Treatment
This study tests whether using dental loupes or a dental operating microscope makes non-surgical periodontal cleaning more effective for adults with periodontitis.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Mandibular molar furcation defects in advanced periodontitis: a regenerative treatment comparison
In people with advanced gum disease, this study tests two regenerative treatments for Hamp Class II furcation defects in lower molars to see which works better and whether CBCT imaging matches what clinicians find during surgery.
-
Omega-3s and low-dose aspirin for smokers with stage III periodontitis
In adults who smoke and have stage III periodontitis, this study tests whether adding omega-3 fatty acids and a small amount of aspirin to standard cleaning helps improve gum health.
-
Bone substitutes with NIPSA for intrabony periodontal defects
This study tests two bone substitutes (GTO and GenOs) used with the NIPSA technique to see which supports better gum and bone healing in adults with Stage III periodontitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.